Chronic open-angle glaucoma, ocular hypertension

Indication for Bimatoprost

Population group: Suitable for both men and women, only adults (18 years old or older)

Bimatoprost is indicated for the reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (as monotherapy or as adjunctive therapy to beta-blockers).

For this indication, competent medicine agencies globally authorize below treatments:

1 drop once daily

Route of admnistration


Defined daily dose

1 - 1 {drops}

Dosage regimen

From 1 To 1 {drops} once every day

Detailed description

The recommended dose is one drop in the affected eye(s) once daily, administered in the evening. The dose should not exceed once daily, as more frequent administration may lessen the intraocular pressure lowering effect.

Active ingredient

Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F (PGF), that does not act through any known prostaglandin receptors.

Read more about Bimatoprost

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner